Daniel P. Ball
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniel P. Ball has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Daniel A. Bachovchin
Pharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
5 shared publications - Andrew R. Griswold
Pharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
4 shared publications - Ashley J. Chui
Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
3 shared publications Cornelius Y. Taabazuing
Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
2 shared publications- Darren C. Johnson
Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
2 shared publications Elizabeth L. Orth-He
Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
2 shared publications
Latest Publications
- 1 February 2023
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (4) , 2589-2607
Optimized M24B Aminopeptidase Inhibitors for CARD8 Inflammasome Activation
Inflammasomes are innate immune signaling platforms that trigger pyroptotic cell death. NLRP1 and CARD8 are related human inflammasomes that detect similar danger signals, but NLRP1 has a higher activation threshold and triggers a more inflammatory form of pyroptosis. Both sense the accumulation of intracellular peptides with Xaa-Pro N-termini, but Xaa-Pro peptides on their own without a second danger signal only activate the CARD8 inflammasome. We recently reported that a dual inhibitor of the Xaa-Pro-cleaving M24B aminopeptidases PEPD and XPNPEP1 called CQ31 selectively activates the CARD8 inflammasome by inducing the build-up of Xaa-Pro peptides. Here, we performed structure-activity relationship studies on CQ31 to develop the optimized dual PEPD/XPNPEP1 inhibitor CQ80 that more effectively induces CARD8 inflammasome activation. We anticipate that CQ80 will become a valuable tool to study the basic biology and therapeutic potential of selective CARD8 inflammasome activation.
- 1 February 2023
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (4) , 2589-2607
Optimized M24B Aminopeptidase Inhibitors for CARD8 Inflammasome Activation
Inflammasomes are innate immune signaling platforms that trigger pyroptotic cell death. NLRP1 and CARD8 are related human inflammasomes that detect similar danger signals, but NLRP1 has a higher activation threshold and triggers a more inflammatory form of pyroptosis. Both sense the accumulation of intracellular peptides with Xaa-Pro N-termini, but Xaa-Pro peptides on their own without a second danger signal only activate the CARD8 inflammasome. We recently reported that a dual inhibitor of the Xaa-Pro-cleaving M24B aminopeptidases PEPD and XPNPEP1 called CQ31 selectively activates the CARD8 inflammasome by inducing the build-up of Xaa-Pro peptides. Here, we performed structure-activity relationship studies on CQ31 to develop the optimized dual PEPD/XPNPEP1 inhibitor CQ80 that more effectively induces CARD8 inflammasome activation. We anticipate that CQ80 will become a valuable tool to study the basic biology and therapeutic potential of selective CARD8 inflammasome activation.
- 25 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (77) , eabm7200
Oxidized thioredoxin-1 restrains the NLRP1 inflammasome
The danger signals that activate the NLRP1 inflammasome have not been established. Here, we report that the oxidized, but not the reduced, form of thioredoxin-1 (TRX1) binds to NLRP1. We found that oxidized TRX1 associates with the NACHT-LRR region of NLRP1 in an ATP-dependent process, forming a stable complex that restrains inflammasome activation. Consistent with these findings, patient-derived and ATPase-inactivating mutations in the NACHT-LRR region that cause hyperactive inflammasome formation interfere with TRX1 binding. Overall, this work strongly suggests that reductive stress, the cellular perturbation that will eliminate oxidized TRX1 and abrogate the TRX1-NLRP1 interaction, is a danger signal that activates the NLRP1 inflammasome.
- 25 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (77) , eabm7200
Oxidized thioredoxin-1 restrains the NLRP1 inflammasome
The danger signals that activate the NLRP1 inflammasome have not been established. Here, we report that the oxidized, but not the reduced, form of thioredoxin-1 (TRX1) binds to NLRP1. We found that oxidized TRX1 associates with the NACHT-LRR region of NLRP1 in an ATP-dependent process, forming a stable complex that restrains inflammasome activation. Consistent with these findings, patient-derived and ATPase-inactivating mutations in the NACHT-LRR region that cause hyperactive inflammasome formation interfere with TRX1 binding. Overall, this work strongly suggests that reductive stress, the cellular perturbation that will eliminate oxidized TRX1 and abrogate the TRX1-NLRP1 interaction, is a danger signal that activates the NLRP1 inflammasome.
- Open Access
- 14 May 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (7) , 102032
A ubiquitin-independent proteasome pathway controls activation of the CARD8 inflammasome
- 14 May 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (7) , 102032
Open AccessA ubiquitin-independent proteasome pathway controls activation of the CARD8 inflammasome
- Open Access
- 1 October 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (2) , 108264
Activation of the CARD8 Inflammasome Requires a Disordered Region
- 1 October 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (2) , 108264
Open AccessActivation of the CARD8 Inflammasome Requires a Disordered Region
- Open Access
- 5 April 2019
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 364 (6435) , 82-85
N-terminal degradation activates the NLRP1B inflammasome
Degradation triggers the alarm: Inflammasomes are multiprotein complexes that orchestrate proinflammatory cytokine secretion and cell death. Proteases such as anthrax lethal factor can activate an inflammasome known as NLRP1B, but the mechanism for this activation has been unclear. Chui et al. used genome-wide knockout screens to show that proteolysis of NLRP1B by lethal factor induces proteasomal degradation of the amino-terminal domains of NLRP1B and eventual cell death. Sandstrom et al. found that degradation of the amino-terminal domains of NLRP1B resulted in the release of a carboxyl-terminal fragment that activates caspase-1. This process, called “functional degradation,” allows the immune system to detect pathogen-associated activities, much as it recognizes pathogen-associated antigens. Science , this issue p. 82 , p. eaau1330
- 5 April 2019
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 364 (6435) , 82-85
Open AccessN-terminal degradation activates the NLRP1B inflammasome
Degradation triggers the alarm: Inflammasomes are multiprotein complexes that orchestrate proinflammatory cytokine secretion and cell death. Proteases such as anthrax lethal factor can activate an inflammasome known as NLRP1B, but the mechanism for this activation has been unclear. Chui et al. used genome-wide knockout screens to show that proteolysis of NLRP1B by lethal factor induces proteasomal degradation of the amino-terminal domains of NLRP1B and eventual cell death. Sandstrom et al. found that degradation of the amino-terminal domains of NLRP1B resulted in the release of a carboxyl-terminal fragment that activates caspase-1. This process, called “functional degradation,” allows the immune system to detect pathogen-associated activities, much as it recognizes pathogen-associated antigens. Science , this issue p. 82 , p. eaau1330